SunRock Biopharma, a Galician biotech firm, develops next-generation antibody-based drugs targeting resistant cancers and immune diseases. Founded by Laureano Simón, it focuses on early clinical phases...
The agreement between the two companies allows Debiopharm to access licensing options to continue the development of SunRock Biopharma's antibodies, integrating Debiopharm's innovative conjugation technologies, called...